Skip to content
OpenCapital
Get started

Forte Biosciences FBRX Q4 2025 Annual earnings

Reported March 31, 2026 · After market close

EPS-$1.45Miss by $0.03
EPS estimate-$1.42

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.92

Versus estimates

Diluted EPS

Q1 2026-$1.24Miss by $0.08
Q4 2025-$1.45Miss by $0.03
Q3 2025-$0.99Beat by $0.05Q2 2025-$0.96Beat by $0.25Q1 2025-$1.37Miss by $0.48Q4 2024-$2.45Beat by $2.10

Ask the moment Forte Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Forte Biosciences report Q4 2025 earnings?
Forte Biosciences (FBRX) reported Q4 2025 earnings on March 31, 2026 after market close.
What were Forte Biosciences's Q4 2025 revenue and EPS?
Forte Biosciences reported eps of $-1.45 for Q4 2025.
Did Forte Biosciences beat estimates in Q4 2025?
EPS missed the consensus estimate of $-1.42 by $0.03.
How did Forte Biosciences's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 40.8% from $-2.45.
Where can I find Forte Biosciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-135767) and the 10-K periodic report (0001193125-26-134498) directly on SEC EDGAR. The filing index links above go to sec.gov.